The IOZK is a translational center and develops immuno-oncological procedures on the basis of new scientific findings.

These are combined in the best possible way for each individual patient. For this reason, no randomized clinical trials are conducted at the IOZK. These require the same treatment protocol for all patients in the experimental group and a comparison group that does not receive any treatment. In science, new research methods are being developed and discussed that are better suited to investigating the effectiveness of a highly individualized therapy. It is very important to us to contribute to scientific progress and the development of modern immunotherapy against tumor diseases.

Here we provide scientific papers published by IOZK employees.